volume 54, issue 4, P197-199 2012
DOI: 10.1590/s0036-46652012000400003
View full text
|
|
Share

Abstract: SUMMARYSystemic fungal infections are responsible for high mortality rates. Several species of fungi may be involved, but Candida spp. is the most prevalent. Simvastatin is used to lower cholesterol and also exhibits antifungal action. The aim of this study was to evaluate the synergistic action of simvastatin with fluconazole against strains of Candida spp. Susceptibility testing was performed according to protocol M27-A3, by broth microdilution method and the synergistic effect of simvastatin and fluconazol…

Expand abstract